Respiratory Alkalosis: Causes, Symptoms, Diagnosis, and Treatment

What Is Respiratory Alkalosis?

Among the many physical and chemical properties that characterize any fluid, such as temperature, color, viscosity, and density, one of the most biologically important is its acidity or alkalinity. This property is quantified by the pH scale. Understanding pH is essential to understanding respiratory alkalosis, so it is worth taking a moment to explore what pH actually means at a molecular level before turning to the clinical condition itself.

The Chemistry of pH: A Molecular Perspective

A molecule of water (H₂O) consists of two hydrogen atoms bonded to one oxygen atom. While water molecules are stable for most of the time, there is a constant, low-level tendency for individual hydrogen atoms to detach from their parent molecule. When this happens, two species are formed:

• A hydroxide ion (OH⁻): The water molecule that lost its hydrogen, now carrying a negative charge
• A hydrogen ion (H⁺): The free hydrogen atom carrying a positive charge (also called a proton)

These ion pairs are chemically unstable and rapidly recombine to form new water molecules. However, they briefly exist as free ions before doing so. The pH of a solution is a measure of the concentration of free hydrogen ions (H⁺) present at any given moment. It is expressed on a logarithmic scale running from 0 to 14:

• pH 0: Maximally acidic (very high H⁺ concentration)
• pH 7: Chemically neutral (H⁺ and OH⁻ concentrations are equal)
• pH 14: Maximally alkaline or basic (very low H⁺ concentration)

The more hydrogen ions are present in a solution, the more acidic it is. Familiar examples include lemon juice (pH ≈ 2, strongly acidic), black coffee (pH ≈ 5, mildly acidic), pure water (pH 7, neutral), and baking soda solution (pH ≈ 8.3, mildly alkaline).

Why Blood pH Is Critical to Life

The pH of body fluids, particularly the pH of the blood, plays a crucial role in physiology. Every protein in the human body, including the enzymes that drive biochemical reactions, the structural proteins that maintain cell architecture, and the hemoglobin that carries oxygen in red blood cells, depends on the precise acid-base environment to maintain its three-dimensional shape and function. Even small deviations in blood pH can distort protein structure, disrupt enzyme activity, alter cell membrane permeability, and interfere with ion channel function.

Blood pH also directly influences three of the body’s most essential physiological processes:

• Respiration: CO₂ (the principal acidic “waste product” of metabolism) is carried in the blood and influences breathing drive via central and peripheral chemoreceptors; pH changes alter this drive
• Renal function: The kidneys regulate acid-base balance by selectively excreting or retaining hydrogen ions and bicarbonate; their response to pH changes is the primary long-term regulatory mechanism
• Red blood cell function: The affinity of hemoglobin for oxygen is directly influenced by pH (the Bohr effect), meaning that blood pH affects how efficiently oxygen is delivered to tissues

For these reasons, the body employs multiple overlapping regulatory systems to maintain arterial blood pH within the remarkably narrow range of 7.35 to 7.45. Even small deviations outside this range, as little as a few hundredths of a pH unit, can produce significant clinical consequences. Values below 6.8 or above 7.8 are generally incompatible with life.

Defining Respiratory Alkalosis

Respiratory alkalosis is an acid-base disorder defined by an elevation of blood pH above 7.45. This condition occurs primarily due to a reduction in the partial pressure of carbon dioxide (PaCO₂) in the blood, also known as hypocapnia. The fall in CO₂ results from increased ventilation (hyperventilation): breathing faster, deeper, or both, which removes CO₂ from the blood more rapidly than it is being produced by cellular metabolism.

The term “respiratory” distinguishes this form of alkalosis from metabolic alkalosis, in which the primary disturbance is an increase in bicarbonate concentration rather than a fall in CO₂.

The physiological logic is as follows: CO₂, when dissolved in blood, reacts with water to form carbonic acid (H₂CO₃), which then dissociates into bicarbonate (HCO₃⁻) and a hydrogen ion (H⁺). When CO₂ levels drop because of hyperventilation, less carbonic acid forms. As a result, fewer hydrogen ions are produced, and blood pH increases. In other words, the blood becomes more alkaline.

Acute vs. Chronic Respiratory Alkalosis

Respiratory alkalosis can develop either acutely (over minutes to hours) or chronically (over days to weeks), and this distinction has important implications for both symptom severity and the body’s compensatory response:

• Acute respiratory alkalosis: The fall in CO₂ occurs rapidly, and the body’s chemical buffer systems respond immediately. However, the kidneys, the most powerful long-term acid-base regulators, have not yet had time to compensate. As a result, blood pH rises significantly and symptoms are typically more pronounced.

• Chronic respiratory alkalosis: When CO₂ has been suppressed for several days or longer, the kidneys have had time to compensate by reducing bicarbonate reabsorption and excreting more bicarbonate in the urine, increasing urinary bicarbonate loss and reducing it in the blood. This renal compensation partially (but never completely) corrects the blood pH, resulting in milder symptoms or even an apparently normal pH with persistently low CO₂.

Understanding whether respiratory alkalosis is acute or chronic is important for both interpretation of blood gas results and for appropriate clinical management.

---

Causes

Respiratory alkalosis is always caused by alveolar hyperventilation, which means an increase in the rate or depth of breathing beyond what is needed to eliminate the CO₂ produced by the body’s metabolic processes. The result is a progressive fall in PaCO₂ and a consequent rise in blood pH.

The causes of hyperventilation are diverse, spanning psychological, physiological, pharmacological, and pathological categories. The most important are outlined below.

Anxiety, Panic, and Psychological Causes

The most common cause of respiratory alkalosis in clinical practice is anxiety, particularly due to the hyperventilation that often accompanies it. During states of acute anxiety, emotional distress, fear, or panic attacks, the respiratory center in the brainstem is stimulated to increase breathing rate and depth without any genuine physiological need for increased oxygen delivery or CO₂ elimination.

This psychologically-driven hyperventilation is often unconscious and involuntary. The person may not realize they are breathing too rapidly. The resulting fall in CO₂ then produces symptoms (tingling, lightheadedness, chest tightness) that may themselves increase anxiety, creating a self-reinforcing cycle of hyperventilation and worsening symptoms.

Other psychological and central nervous system causes include:

• Neurosis and somatization disorders: Chronic hyperventilation as a functional somatic symptom
• Pain: Both acute and chronic pain can reflexively increase breathing rate, producing respiratory alkalosis as a side effect
• Central nervous system disorders:
  • Stroke: Lesions in the brainstem or cortical areas affecting respiratory control centers
  • Seizures: Can alter breathing patterns during and after ictal events
  • Encephalitis: Brain inflammation may directly stimulate respiratory centers
  • Meningitis: Meningeal irritation and raised intracranial pressure can drive hyperventilation

Hypoxia and Conditions Increasing Metabolic Demand

Any condition that reduces the amount of oxygen available to tissues, or that increases the body’s metabolic rate and therefore its rate of CO₂ production, can reflexively stimulate increased ventilation. When the ventilatory response is disproportionately large relative to the true CO₂ load, PaCO₂ falls and respiratory alkalosis results:

• Altitude exposure and altitude sickness: At high altitude, the partial pressure of oxygen in the atmosphere is reduced. Peripheral chemoreceptors in the carotid bodies detect the reduced oxygen delivery and signal the respiratory center to increase ventilation. This initially appropriate response causes CO₂ to be “blown off” and respiratory alkalosis to develop. Acclimatization over days to weeks involves renal compensation (bicarbonate excretion), but some degree of hypocapnia persists at altitude.

• Fever: Elevated body temperature increases the metabolic rate and CO₂ production, but the respiratory response is often disproportionate, leading to net hypocapnia.

• Anemia: Reduced oxygen-carrying capacity of the blood (due to low hemoglobin) stimulates compensatory hyperventilation to maintain oxygen delivery, potentially causing respiratory alkalosis.

• Hyperthyroidism: Excess thyroid hormone dramatically increases the body’s basal metabolic rate and oxygen consumption, driving compensatory hyperventilation.

• Pulmonary conditions that stimulate stretch receptors or J-receptors:

  • Pulmonary embolism: A potentially life-threatening cause of respiratory alkalosis that is critically important not to miss. Pulmonary emboli stimulate afferent nerve fibers in the lung, reflexively increasing breathing rate. Respiratory alkalosis in the context of acute breathlessness and hypoxia should always prompt consideration of pulmonary embolism.
  • Pneumonia: Pulmonary infiltrates can stimulate J-receptors and reduce compliance, driving hyperventilation
  • Pulmonary edema: Both cardiogenic and non-cardiogenic pulmonary edema can cause reflex hyperventilation
  • Asthma and interstitial lung disease: In their early and mild phases, these conditions can drive compensatory hyperventilation, producing respiratory alkalosis before hypoxia and acidosis supervene in more severe disease

Pharmacological and Toxic Causes

Certain drugs and toxins can stimulate the respiratory center directly or indirectly:

• Aspirin (salicylates) and salicylate poisoning: One of the most important pharmacological causes of respiratory alkalosis. Salicylates directly stimulate the respiratory center in the medulla. This stimulation leads to marked hyperventilation and respiratory alkalosis. Afterward, a metabolic acidosis usually develops because of the toxic effects of salicylates on cellular metabolism. The combination of respiratory alkalosis and metabolic acidosis in a patient with altered consciousness should immediately raise suspicion of salicylate toxicity.

• Other drugs: Progesterone, which explains how pregnancy causes hyperventilation (as discussed below), along with theophylline, catecholamines, and certain CNS stimulants, can increase ventilatory drive.

• Excessive sodium bicarbonate ingestion: Paradoxically, large doses of sodium bicarbonate can stimulate ventilation through mechanisms related to the acute acid-base disturbance produced.

• Carbon monoxide poisoning: Reduces the oxygen-carrying capacity of hemoglobin, reflexively stimulating hyperventilation.

• Nicotine: Can transiently stimulate the carotid body chemoreceptors and increase ventilatory drive.

Physiological States

• Pregnancy: One of the most common “physiological” causes of respiratory alkalosis. The hormone progesterone, which rises markedly during pregnancy, is a direct respiratory stimulant. Pregnant women consistently maintain a PaCO₂ of approximately 28–32 mmHg (compared to the normal 35–45 mmHg), resulting in a mild, compensated respiratory alkalosis throughout pregnancy. This is a normal adaptation of pregnancy and does not require treatment.

• Mechanical ventilation: Patients on mechanical ventilators can develop iatrogenic respiratory alkalosis if ventilator settings deliver excessive minute ventilation relative to the patient’s metabolic needs. Careful adjustment of respiratory rate and tidal volume settings is required.

Summary: Acute vs. Chronic Classification

As noted in the introduction, respiratory alkalosis can be classified as:

• Acute: Not yet compensated by renal mechanisms (kidneys have not had time to reduce bicarbonate). Blood pH is significantly elevated. Symptoms are more pronounced. Typical causes: acute anxiety/panic, acute pain, acute pulmonary embolism, early salicylate toxicity.

• Chronic: Partially or substantially compensated by renal bicarbonate excretion (kidneys have had days to weeks to respond). Blood pH may be close to or within the normal range despite persistently low PaCO₂. Symptoms are milder. Typical causes: residence at high altitude, chronic pulmonary disease, pregnancy, chronic anxiety disorder with persistent hyperventilation syndrome.

---

Symptoms

The symptoms of respiratory alkalosis are produced by two principal mechanisms: the direct effects of hypocapnia (low CO₂) on cerebral blood flow and neuronal function, and the indirect effects of alkalosis on calcium and electrolyte balance, particularly the reduction in ionized calcium that occurs as blood pH rises.

The Physiological Basis of Symptoms

Carbon dioxide as a cerebral vasodilator: Under normal conditions, CO₂ exerts a powerful vasodilatory effect on the cerebral vasculature. This refers to the blood vessels supplying the brain. This is one reason why breathing into a paper bag (re-breathing exhaled CO₂) relieves many symptoms of hyperventilation: restoring CO₂ dilates cerebral vessels and improves cerebral blood flow. Conversely, when CO₂ falls due to hyperventilation, cerebral vessels constrict (cerebral vasoconstriction), reducing brain perfusion and producing neurological symptoms. The brain, despite receiving fully oxygenated blood, becomes relatively ischemic because the vessels are constricted.

Alkalosis and ionized calcium: As blood pH rises (becomes more alkaline), the binding of calcium ions to plasma proteins (primarily albumin) increases. This shift moves calcium from its free and ionized form, which is the biologically active form, to the protein-bound form. As a result, the concentration of ionized calcium (Ca²⁺) in the blood decreases, leading to a condition known as hypocalcemia, specifically hypocalcemia of the ionized fraction. Since ionized calcium plays a crucial role in nerve impulse transmission and muscle contraction, its reduction dramatically increases the excitability of nerves and muscles, producing the characteristic peripheral neurological symptoms of respiratory alkalosis.

Alkalosis and hemoglobin oxygen affinity: Alkalosis shifts the oxygen-hemoglobin dissociation curve to the left (the Bohr effect), meaning that hemoglobin binds oxygen more tightly and releases it less readily to tissues. The paradoxical consequence is that even with adequate blood oxygenation, tissues may receive less oxygen than they need. This can contribute to cellular energy deficits and some of the systemic symptoms of respiratory alkalosis.

Neurological Symptoms: Cerebrovascular Effects

The reduction in cerebral blood flow caused by hypocapnia-driven vasoconstriction produces a characteristic cluster of neurological symptoms:

• Confusion and impaired concentration: A sense of mental cloudiness, difficulty focusing, and disorientation. This is often one of the first symptoms noticed, though it is frequently misattributed to the anxiety causing the hyperventilation in the first place
• Dizziness and lightheadedness: A floating, unsteady sensation that can be quite alarming and may reinforce the anxiety driving the hyperventilation
• Nausea: Due to a combination of cerebral and vestibular effects
• Visual disturbances: Blurring of vision, tunnel vision, or flickering lights can occur with significant cerebral vasoconstriction
• Syncope (fainting): In severe or prolonged hyperventilation, cerebral perfusion may fall sufficiently to cause brief loss of consciousness. This is more common in individuals who are also standing (where orthostatic factors reduce cerebral perfusion further)
• Coma: In extreme cases of severe, sustained respiratory alkalosis, especially when caused by toxins like salicylate poisoning, loss of consciousness can progress to coma. This represents a medical emergency

Neuromuscular Symptoms: Hypocalcemia Effects

The reduction in ionized calcium produced by alkalosis increases the excitability of peripheral nerves and muscles, producing a distinctive neuromuscular symptom complex:

• Paresthesias (tingling and numbness): The most common peripheral symptom. Tingling or numbness typically affects:

  • The fingers and hands (most commonly)
  • The toes and feet
  • The perioral region (around the mouth and lips) is a particularly characteristic location that reflects the high sensitivity of the trigeminal nerve territory to changes in ionized calcium

• Muscle rigidity and fasciculations: Increased neuromuscular excitability can manifest as visible muscle twitching (fasciculations) and a sensation of muscle stiffness or rigidity

• Muscle spasms: Painful, sustained involuntary contractions of muscles, particularly in the hands. The characteristic posture known as “carpal spasm” or “obstetrician’s hand” (flexion of the wrist, extension of the fingers, and adduction of the thumb) may develop

• Tetany: In severe cases, the combination of profound hypocalcemia, alkalosis, and electrolyte disturbances can produce frank tetany, which is sustained involuntary tonic muscle contractions affecting multiple muscle groups simultaneously. This can be elicited clinically by:

  • Chvostek’s sign: Tapping over the facial nerve in front of the ear produces ipsilateral facial muscle twitching
  • Trousseau’s sign: Inflating a blood pressure cuff above systolic pressure for three minutes causes carpal spasm

Cardiovascular Symptoms

The effects of respiratory alkalosis on the cardiovascular system are mediated by both the direct effects of pH and CO₂ on cardiac and vascular physiology, and the indirect effects of electrolyte disturbances:

• Palpitations: A subjective awareness of an abnormal heartbeat, often described as fluttering, pounding, or racing, is common during hyperventilation.
• Extrasystoles (premature beats): Alkalosis and the associated hypokalemia increase cardiac excitability, predisposing to premature atrial or ventricular contractions.
• Cardatic arrhythmias: More significant arrhythmias can occur, including supraventricular tachycardias. In patients with pre-existing heart disease or in the context of severe alkalosis with hypokalemia, potentially dangerous ventricular arrhythmias may also develop. Patients with underlying cardiac disease are at particularly increased risk.
• Chest tightness: Often reported during hyperventilation episodes, contributing to the anxiety and fear that perpetuate the cycle

Respiratory Symptoms

Paradoxically, despite breathing fast (the cause of the problem), patients with respiratory alkalosis often experience a distressing sense of breathlessness or air hunger. This likely reflects:

• Altered respiratory drive as CO₂ falls below the normal stimulus range for comfortable breathing
• Increased respiratory muscle work from sustained hyperventilation
• Anxiety and the psychological experience of the hyperventilation episode

Symptom Severity and the Acute/Chronic Distinction

It is important to emphasize that symptoms are substantially more severe and pronounced in acute respiratory alkalosis than in the chronic form. In chronic respiratory alkalosis (e.g., adaptation to altitude, pregnancy), the renal compensatory response reduces bicarbonate, bringing pH close to the normal range. Symptoms may be absent or very mild despite persistently low PaCO₂ levels. In acute respiratory alkalosis (e.g., panic attack, acute pain), the pH elevation is larger and more rapid, and the full symptom complex is more likely to develop.

Mild respiratory alkalosis may be completely asymptomatic.

---

Diagnosis

The diagnosis of respiratory alkalosis requires objective laboratory evidence of elevated blood pH with reduced PaCO₂. Clinical assessment alone cannot definitively establish the diagnosis or quantify its severity, and specific investigations are essential both to confirm the acid-base disorder and to identify its underlying cause.

Arterial Blood Gas Analysis (ABG)

The arterial blood gas (ABG) test is the definitive investigation for diagnosing and characterizing respiratory alkalosis. A sample of arterial blood is obtained, typically by puncturing the radial artery at the wrist (though the femoral or brachial artery may be used as alternatives). Arterial puncture is more uncomfortable than a venous blood draw, and patient cooperation is important.

The ABG measures:

• Blood pH: Elevated above 7.45 in respiratory alkalosis (confirming alkalemia).
• PaCO₂ (partial pressure of CO₂ in arterial blood): Reduced below the normal range (35–45 mmHg), the primary abnormality in respiratory alkalosis. The degree of CO₂ reduction reflects the severity of hyperventilation.
• HCO₃⁻ (bicarbonate concentration): In acute respiratory alkalosis, bicarbonate is initially normal or only slightly reduced (the chemical buffer response lowers it slightly). In chronic respiratory alkalosis, bicarbonate is more substantially reduced due to renal compensation (the kidneys excrete more bicarbonate in urine). Expected compensation: in acute respiratory alkalosis, HCO₃⁻ falls by approximately 2 mEq/L for every 10 mmHg fall in PaCO₂; in chronic respiratory alkalosis, by approximately 4–5 mEq/L per 10 mmHg fall in PaCO₂.
• PaO₂ (partial pressure of oxygen) and oxygen saturation (SaO₂): Essential to assess whether hypoxia is present, which would indicate a pulmonary or circulatory cause of the hyperventilation rather than a purely psychological one
• Base excess (BE): In respiratory alkalosis, the base excess may be slightly positive in acute forms and tends toward zero or mildly negative in chronic forms as renal compensation occurs.

Interpreting the ABG in respiratory alkalosis:

• Acute respiratory alkalosis: pH > 7.45, PaCO₂ low, HCO₃⁻ normal or minimally reduced
• Chronic respiratory alkalosis: pH at or near upper limit of normal (fully or partially compensated), PaCO₂ low, HCO₃⁻ substantially reduced
• Mixed disorders: If both PaCO₂ and HCO₃⁻ are reduced but pH is more alkaline than the chronic compensation formula would predict, a co-existing metabolic alkalosis should be considered. Conversely, if pH is lower than expected for the degree of CO₂ reduction, a co-existing metabolic acidosis is likely.

Serum Electrolytes

A venous blood sample for serum electrolyte measurement is an essential complementary investigation, providing information about:

• Potassium (K⁺): Alkalosis promotes the intracellular movement of potassium (in exchange for hydrogen ions shifting out of cells to buffer the alkalosis), producing mild hypokalemia in many cases of respiratory alkalosis. Hypokalemia independently increases cardiac arrhythmia risk and must be identified and managed.

• Calcium (Ca²⁺): Total serum calcium may be normal, but the physiologically important ionized calcium is reduced in respiratory alkalosis (due to increased protein binding in alkaline conditions). Where available, direct measurement of ionized calcium (from the ABG sample or a separate test) is more informative than total calcium measurement.

• Magnesium (Mg²⁺): Hypomagnesemia may co-exist (particularly in conditions where electrolyte losses are occurring) and contributes to neuromuscular excitability and cardiac arrhythmia risk.

• Chloride (Cl⁻): May be elevated (hyperchloremia) in chronic respiratory alkalosis as the kidneys retain chloride to compensate for bicarbonate excretion.

• Sodium (Na⁺): Generally normal in isolated respiratory alkalosis.

The clinical importance of electrolyte assessment cannot be overstated: these ions play critical roles in cardiac muscle function, heart rhythm regulation, and blood pressure maintenance, and their abnormalities may predict or explain the development of arrhythmias.

Identifying the Underlying Cause

While the ABG and electrolytes confirm the presence of respiratory alkalosis, identifying and treating its underlying cause is the most clinically important aspect of diagnosis. The cause is often apparent from the clinical history alone, such as a young person presenting after an anxiety attack, a patient at altitude, or a pregnant woman. However, in other cases, a systematic diagnostic approach is required.

Key diagnostic considerations include:

• Clinical history: Duration and context of hyperventilation, associated symptoms, current medications (particularly salicylates), altitude of residence, pregnancy status, history of anxiety or panic disorder, recent trauma or pain

• Physical examination: Signs of respiratory distress, cyanosis, fever, neurological examination, cardiovascular examination

• Exclusion of life-threatening causes:

  • Pulmonary embolism must be actively considered and excluded in any patient presenting with acute dyspnea, tachycardia, hypoxia, and respiratory alkalosis, even when anxiety seems a plausible explanation. A premature diagnosis of “anxiety hyperventilation” in a patient with pulmonary embolism can be fatal. Clinical probability scoring (e.g., Wells score), D-dimer testing, and CT pulmonary angiography should be employed when clinical suspicion exists.
  • Salicylate toxicity should be considered in any patient with unexplained respiratory alkalosis and altered consciousness, particularly if there is a history of medication ingestion.

• Further investigations depending on suspected cause:

  • Chest X-ray and CT pulmonary angiography (to evaluate pulmonary causes)
  • Thyroid function tests (to evaluate hyperthyroidism)
  • Complete blood count (to evaluate anemia)
  • Blood cultures and inflammatory markers (if infection is suspected)
  • Serum salicylate level (if toxicity is suspected)
  • Brain imaging (CT or MRI) if CNS cause is suspected
  • Echocardiography (if cardiac cause of hypoxia is considered)

---

Treatment

The management of respiratory alkalosis is guided by a fundamental principle: treating the underlying cause of the hyperventilation. Because respiratory alkalosis is rarely fatal in isolation (unlike metabolic acidosis or severe metabolic alkalosis, which can be immediately life-threatening), the urgent goal is to identify and address the condition driving the hyperventilation, rather than to rapidly correct the blood pH pharmacologically.

Ensuring Adequate Oxygenation

The first priority in any patient with respiratory alkalosis is to ensure adequate oxygen delivery to the tissues. When hypoxia is the driver of hyperventilation, as in pulmonary embolism, pneumonia, pulmonary edema, or altitude sickness, supplemental oxygen should be administered immediately to correct the hypoxia. This will reduce the reflex drive to hyperventilate.

This is particularly important because, as noted above, some patients presenting with apparent anxiety-related hyperventilation may actually have a serious underlying hypoxic condition driving their rapid breathing.

Treating the Underlying Cause

The specific treatment of respiratory alkalosis depends entirely on its cause:

Anxiety and Panic Disorder

When anxiety or a panic attack is the identified cause of hyperventilation, the immediate management focuses on calming the patient and slowing their breathing:

• Reassurance and emotional support: A calm, confident, reassuring approach by the clinician or first responder can significantly reduce the anxiety driving the hyperventilation. Explaining what is happening (“Your breathing is too fast, which is causing these symptoms; if you slow down your breathing, the symptoms will improve”) can itself reduce fear and break the anxiety-hyperventilation cycle.

• Breathing retraining: Instructing the patient to consciously slow and deepen their breathing is often sufficient to resolve an acute episode. Paced breathing exercises (breathing in for a count of four, holding for a count of two, and breathing out slowly for a count of six) can help the patient regain control of their respiratory rate.

• Rebreathing into a paper bag: A well-known and sometimes effective technique is to have the patient breathe slowly in and out of a paper bag (importantly, not a plastic bag, which could cause suffocation if it seals around the face). By rebreathing exhaled air containing elevated CO₂, the patient can rapidly restore their PaCO₂ toward normal, reversing the alkalosis and resolving symptoms.

  However, this technique must be used with caution and clinical judgment. It is specifically contraindicated when:

  • The cause of hyperventilation has not been established and hypoxia cannot be excluded (rebreathing CO₂ in the context of hypoxia can be dangerous)
  • CNS dysfunction is suspected, as the pH of cerebrospinal fluid may already be abnormal in some central causes of hyperventilation
  • The patient cannot cooperate with the technique

  Because of these caveats, paper bag rebreathing should not be used automatically in all cases of apparent hyperventilation. A brief clinical assessment is essential first to ensure that the cause is truly anxiety-related and that oxygen saturation is normal.

• Long-term management of anxiety and panic disorder: For patients with recurrent hyperventilation due to chronic anxiety, panic disorder, or neurosis, a structured long-term treatment plan is essential:

  • Psychotherapy: Cognitive-behavioral therapy (CBT) is the psychological treatment with the strongest evidence base for anxiety and panic disorder. It targets the maladaptive thought patterns and behavioral responses (including hyperventilation) that perpetuate the anxiety cycle.
  • Breathing physiotherapy: Specialist physiotherapy focused on correcting maladaptive breathing patterns can be very effective, particularly for patients with chronic hyperventilation syndrome.
  • Relaxation techniques: Diaphragmatic breathing training, progressive muscle relaxation, mindfulness meditation, and similar techniques can reduce baseline anxiety levels and provide tools for managing acute episodes.
  • Anxiolytic medication: Under medical supervision, short-term anxiolytic medications (such as benzodiazepines for acute episodes) or longer-term medications (SSRIs or SNRIs for chronic anxiety) may be indicated in some patients. These decisions should involve the patient’s primary physician or psychiatrist.
  • Natural anti-stress therapies: Lifestyle measures including regular physical exercise, adequate sleep, stress management strategies, and reduction of caffeine and stimulant intake can meaningfully reduce the frequency and severity of anxiety-related hyperventilation.

Pain

When respiratory alkalosis is driven by acute pain, effective pain management will typically resolve the hyperventilation:

• Appropriate analgesia (pain relief medication) tailored to the cause and severity of pain: from simple analgesics (paracetamol, NSAIDs) for mild pain to opioid analgesia for severe acute pain, administered under medical supervision
• Treatment of the underlying painful condition

Physiological and Medical Causes

• Fever: Antipyretics (paracetamol, NSAIDs) to reduce temperature; treatment of the underlying infection or inflammatory cause.
• Anemia: Identification and treatment of the cause; iron supplementation, B12/folate supplementation, or blood transfusion depending on type and severity.
• Hyperthyroidism: Antithyroid medications (methimazole, propylthiouracil), radioiodine therapy, or surgical thyroidectomy as appropriate.
• Pulmonary embolism: Anticoagulation with low-molecular-weight heparin followed by oral anticoagulant therapy. In massive or submassive embolism, thrombolysis or catheter-directed therapy may be indicated. This is a medical emergency requiring immediate hospital management.
• Pregnancy: No specific treatment is needed for the physiological respiratory alkalosis of pregnancy; it is a normal adaptation and resolves after delivery
• Altitude sickness: Gradual acclimatization; descent to lower altitude if severe; acetazolamide (which promotes renal bicarbonate excretion and partially corrects the alkalosis) in appropriate cases

Salicylate Toxicity

Salicylate poisoning causing respiratory alkalosis is a medical emergency requiring:

• Immediate hospitalization and monitoring
• Gastric decontamination (activated charcoal if presentation is early)
• Urinary alkalinization with intravenous sodium bicarbonate (to promote salicylate excretion)
• Correction of fluid and electrolyte disturbances
• Hemodialysis in severe cases with very high salicylate levels, severe acidosis, or organ failure

Iatrogenic (Ventilator-Related)

In mechanically ventilated patients, respiratory alkalosis due to excessive ventilation is corrected by adjusting ventilator settings to reduce the respiratory rate and/or tidal volume, thereby allowing PaCO₂ to normalize.

Electrolyte Management

Regardless of the underlying cause, significant electrolyte disturbances identified during the diagnostic workup should be corrected:

• Hypokalemia: Oral or intravenous potassium supplementation with careful monitoring to avoid overcorrection
• Hypocalcemia (ionized): In mild cases, correction of the alkalosis itself will restore ionized calcium to normal; in severe cases, calcium gluconate may be administered intravenously
• Hypomagnesemia: Oral or intravenous magnesium supplementation

Monitoring

Following initiation of treatment, patients should be monitored with:

• Serial ABG analyses to document normalization of pH and PaCO₂
• Repeat serum electrolytes to assess response to supplementation
• Continuous or regular ECG monitoring in patients with significant alkalosis or co-existing cardiac disease
• Clinical assessment for resolution of symptoms (paresthesias, muscle spasms, confusion, palpitations)

---

Sources and Bibliography

• MSD Manuals (Professional Edition) – Respiratory Alkalosis
• Palmer, B.F. (2012). “Evaluation and treatment of respiratory alkalosis”. American Journal of Kidney Diseases, 60(5), 834–838. doi: 10.1053/j.ajkd.2012.03.025
• Berend, K., de Vries, A.P.J., & Gans, R.O.B. (2014). “Physiological approach to assessment of acid-base disturbances”. New England Journal of Medicine, 371(15), 1434–1445.
• Laffey, J.G., & Kavanagh, B.P. (2002). “Hypocapnia”. New England Journal of Medicine, 347(1), 43–53.
• Martinu, T., Menzies, D., & Dial, S. (2003). “Re-evaluation of acid-base prediction rules in patients with chronic respiratory acidosis”. Canadian Respiratory Journal, 10(6), 311–315.
• Guyton, A.C., & Hall, J.E. (2016). Textbook of Medical Physiology (13th ed.). Elsevier Saunders.
• Goldman, L., & Schafer, A.I. (Eds.). (2020). Goldman-Cecil Medicine (26th ed.). Elsevier.
• Brashear, R.E. (1983). “Hyperventilation syndrome”. Lung, 161(1), 257–273.
• Gardner, W.N. (1996). “The pathophysiology of hyperventilation disorders”. Chest, 109(2), 516–534.